Nov 16, 2022 / 08:35PM GMT
Dan Arias - Stifel Financial Corp. - Analyst
(technical difficulty) started here. We are back on the life sciences and diagnostics track of the Stifel Healthcare Conference. Happy to have the gentlemen from Renalytix here with us: James McCullough, CEO; Chief Technology Officer, Fergus Fleming. Thanks (inaudible) for joining us here today.
Questions and Answers:
Dan Arias - Stifel Financial Corp. - AnalystJames, what I've been doing with a lot of these companies is starting with a -- maybe you can give us an overview of the business? What do you do? What you do well? What solution in the market are you solving?
James McCullough - Renalytix plc - CEO & Director
Thanks, Dan. Thanks for having us here. We're delighted to be here. One of the biggest unmet needs that we face today is understanding how to manage chronic disease. That is really one of the biggest challenges of this century. It creates so much cost, suffering. And today, we have the diagnostic tools. We have the therapeutic tools. We have a policy